Philippines Begins HIV PrEP Pilot Project Among Gay Men, Transgender Women As New Cases Hit Record High

Thomson Reuters Foundation: Philippines trials anti-HIV drug as cases hit record high
“The Philippines has kicked off a pilot project offering anti-HIV drugs to gays and transgender women as new infection rates in the country buck global trends and hit a record high. Under the project, 200 HIV-negative gay men and transgender women will be given a daily pill known as PrEP that is designed to protect the body pre-exposure…” (Yi, 7/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.